95 related articles for article (PubMed ID: 7229511)
1. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
Magon AM; Leipzig RM; Zannoni VG; Brewer GJ
J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
Magon A; Leipzig RM; Bloom K; Brewer GJ
Prog Clin Biol Res; 1981; 55():709-24. PubMed ID: 7291202
[TBL] [Abstract][Full Text] [Related]
3. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Grossman S; Budinsky R; Jollow D
J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel mouse model of severe glucose-6-phosphate dehydrogenase (G6PD)-deficiency for in vitro and in vivo assessment of hemolytic toxicity to red blood cells.
Ko CH; Li K; Li CL; Ng PC; Fung KP; James AE; Wong RP; Gu GJ; Fok TF
Blood Cells Mol Dis; 2011 Oct; 47(3):176-81. PubMed ID: 21839656
[TBL] [Abstract][Full Text] [Related]
5. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
6. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
Wang YM; Patterson JH; Van Eys J
J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
[TBL] [Abstract][Full Text] [Related]
7. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
Dziewulska KH; Reisz JA; Hay AM; D'Alessandro A; Zimring JC
J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
[TBL] [Abstract][Full Text] [Related]
8. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Bluhm RE; Adedoyin A; McCarver DG; Branch RA
Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665
[TBL] [Abstract][Full Text] [Related]
9. Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes.
Jain M; Brenner DA; Cui L; Lim CC; Wang B; Pimentel DR; Koh S; Sawyer DB; Leopold JA; Handy DE; Loscalzo J; Apstein CS; Liao R
Circ Res; 2003 Jul; 93(2):e9-16. PubMed ID: 12829617
[TBL] [Abstract][Full Text] [Related]
10. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
Bashan N; Peleg N; Moses SW
Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
[No Abstract] [Full Text] [Related]
11. Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro.
Ko CH; Li K; Ng PC; Fung KP; Wong RP; Chui KM; Gu GJ; Yung E; Fok TF
Toxicol In Vitro; 2008 Aug; 22(5):1222-7. PubMed ID: 18515042
[TBL] [Abstract][Full Text] [Related]
12. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance.
Tang HY; Ho HY; Wu PR; Chen SH; Kuypers FA; Cheng ML; Chiu DT
Antioxid Redox Signal; 2015 Mar; 22(9):744-59. PubMed ID: 25556665
[TBL] [Abstract][Full Text] [Related]
13. Acetylator phenotype among individuals with glucose 6-phosphate dehydrogenase variants.
Jeyakumar LH; French MR
Xenobiotica; 1986 Dec; 16(12):1129-32. PubMed ID: 3798960
[TBL] [Abstract][Full Text] [Related]
14. Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages.
Wilmanski J; Siddiqi M; Deitch EA; Spolarics Z
J Leukoc Biol; 2005 Jul; 78(1):85-94. PubMed ID: 15817708
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
Jacobasch G; Bleiber R; Schönian G
Haematologia (Budap); 1982 Dec; 15(4):401-7. PubMed ID: 7186479
[TBL] [Abstract][Full Text] [Related]
16. [Changes of protein tyrosine phosphorylation in erythrocyte band 3 glucose-6-phosphate dehydrogenase deficiency].
Yu G; Li J; Tian X; Lin H; Wang X
Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):565-7. PubMed ID: 12482337
[TBL] [Abstract][Full Text] [Related]
17. G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
Moore GS; Calabrese EJ
J Environ Pathol Toxicol; 1980 Sep; 4(2-3):271-9. PubMed ID: 7462905
[TBL] [Abstract][Full Text] [Related]
18. Influence of double genetic polymorphism on response to sulfamethazine.
Woolhouse NM; Atu-Taylor LC
Clin Pharmacol Ther; 1982 Mar; 31(3):377-83. PubMed ID: 7060320
[TBL] [Abstract][Full Text] [Related]
19. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Ali NA; al-Naama LM; Khalid LO
East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced hemolysis: biochemical considerations.
Shahidi NT
Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
